Patent Eligibility: Exploring the Intersection Between Patent Law and Biomedical Data

Abstract

The world was fundamentally changed by the rampant spread of COVID-19 in 2020. This is not the first and will not be the last time the world is faced with a pandemic. Thus, it is essential to  take the necessary steps now to be prepared in the future. This Note will address how patent law can protect inventions incorporating the biomedical data to prevent future pandemics. The Note compares U.S. and European Patent Regimes to determine which system is better at protecting biomedical data. Lastly, this Note proposes changes to the U.S. Patent Regime to help increase its compatibility with biomedical data

Similar works

Full text

Pittsburgh Journal of Technology Law and Policy (University of Pittsburgh)

redirect
Last time updated on 03/06/2021

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.